Sanjoy K. Das
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Quantitative 1H-NMR spectroscopy identifies metabolites and lipoprotein subclasses associated with intermediate phenotypes of chronic diseases in the Japanese Nagahama Study.
Journal: Scientific reports
Published: April 04, 2025
In Silico Modeling of Myelin Oligodendrocyte Glycoprotein Disulfide Bond Reduction by Phosphine-Borane Complexes.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 20, 2024
Predicting Absorption-Distribution Properties of Neuroprotective Phosphine-Borane Compounds Using In Silico Modeling and Machine Learning.
Journal: Molecules (Basel, Switzerland)
Published: January 31, 2021
Examination of VDR/RXR/DRIP205 Interaction, Intranuclear Localization, and DNA Binding in Ras-Transformed Keratinocytes and Its Implication for Designing Optimal Vitamin D Therapy in Cancer.
Journal: Endocrinology
Published: November 01, 2017
Extraembryonic heparin-binding epidermal growth factor-like growth factor deficiency compromises placentation in mice.
Journal: Biology of reproduction
Published: December 20, 2016
Discovery of Novel Allosteric HCV NS5B Inhibitors. 2. Lactam-Containing Thiophene Carboxylates.
Journal: ACS medicinal chemistry letters
Published: November 28, 2016
Discovery of Novel Thiophene-Based, Thumb Pocket 2 Allosteric Inhibitors of the Hepatitis C NS5B Polymerase with Improved Potency and Physicochemical Profiles.
Journal: Journal of medicinal chemistry
Published: July 02, 2016
Polycomb repressive complex 1 controls uterine decidualization.
Journal: Scientific reports
Published: January 12, 2016
Control of regional decidualization in implantation: Role of FoxM1 downstream of Hoxa10 and cyclin D3.
Journal: Scientific reports
Published: April 10, 2015
Synthesis and evaluation of NS5A inhibitors containing diverse heteroaromatic cores.
Journal: Bioorganic & medicinal chemistry letters
Published: October 24, 2014
Discovery of thienoimidazole-based HCV NS5A inhibitors. Part 2: non-symmetric inhibitors with potent activity against genotype 1a and 1b.
Journal: Bioorganic & medicinal chemistry letters
Published: October 24, 2014
Discovery of thienoimidazole-based HCV NS5A inhibitors. Part 1: C2-symmetric inhibitors with diyne and biphenyl linkers.
Journal: Bioorganic & medicinal chemistry letters
Published: October 24, 2014
Last Updated: 09/26/2026